Your browser doesn't support javascript.
loading
Procalcitonina como biomarcador diagnóstico de sepsis en el niño con cáncer, neutropenia y fiebre: revisión de la literatura. / [Procalcitonin as a diagnostic biomarker of sepsis in children with cancer, fever and neutropenia: literature review].
Arch Argent Pediatr ; 113(1): 46-52, 2015 Jan.
Article in Es | BINACIS | ID: bin-133784
ABSTRACT
Among cancer and septic patients, there is a deregulation of common events such as inflammation. This fact limits the use of biomarkers to diagnose sepsis. Through a search in the PubMed database, we identified the clinical studies that evaluated procalcitonin as a biomarker among children with cancer and sepsis; we analyzed its characteristics, advantages and disadvantages. Most of the studies suggest that with a cut-off point between 0.5 ng/dl and 1 mg/dl, procalcitonin displays a sensitivity of 59-78
Search on Google
Collection: 06-national / AR Database: BINACIS Type of study: Diagnostic_studies / Prognostic_studies Language: Es Journal: Arch Argent Pediatr Year: 2015 Document type: Article Country of publication: Argentina
Search on Google
Collection: 06-national / AR Database: BINACIS Type of study: Diagnostic_studies / Prognostic_studies Language: Es Journal: Arch Argent Pediatr Year: 2015 Document type: Article Country of publication: Argentina